scholarly journals Efficacy of Diacetate Esters of Macular Carotenoids: Effect of Supplementation on Macular Pigment

2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Richard A. Bone ◽  
John T. Landrum ◽  
Anirbaan Mukherjee

The accumulation of the carotenoids lutein, zeaxanthin, and mesozeaxanthin in the center of the human retina, and known as the macula lutea or macular pigment, is believed to protect the retina from age-related macular degeneration. Since the macular pigment is of dietary origin, supplements containing the relevant carotenoids are readily available. In this study, we compared the changes in macular pigment over a 24-week supplementation period for two groups of 24 subjects each assigned to either of two supplement formulations, 20 mg/day of lutein or 20 mg equivalent free carotenoids of a combination of diacetate esters of the macular carotenoids. The latter group responded with a larger increase (0.0666 ± 0.0481) in macular pigment optical density than the former group (0.0398 ± 0.0430), driven largely by the older subjects. The difference was statistically significant (p=0.0287). There was a general trend towards smaller increases in macular pigment for those subjects whose baseline value was high. However, the trend was only significant (p<0.05) for subjects in the diacetate group. No differences in response could be attributed to the gender of the subjects. We also observed no indication that the use of statin drugs by a few of the older subjects influenced their responses.

2020 ◽  
Vol 9 (5) ◽  
pp. 1347 ◽  
Author(s):  
Norihiro Nagai ◽  
Sakiko Minami ◽  
Misa Suzuki ◽  
Hajime Shinoda ◽  
Toshihide Kurihara ◽  
...  

To explore predisease biomarkers, which may help screen for the risk of age-related macular degeneration (AMD) at very early stages, macular pigment optical density (MPOD) and photoreceptor outer segment (PROS) length were analyzed. Thirty late AMD fellow eyes, which are at high risk and represent the predisease condition of AMD, were evaluated and compared with 30 age-matched control eyes without retinal diseases; there was no early AMD involvement in the AMD fellow eyes. MPOD was measured using MPS2® (M.E. Technica Co. Ltd., Tokyo, Japan), and PROS length was measured based on optical coherence tomography images. MPOD levels and PROS length in the AMD fellow eyes were significantly lower and shorter, respectively, than in control eyes. MPOD and PROS length were positively correlated in control eyes (R = 0.386; p = 0.035) but not in AMD fellow eyes. Twenty (67%) AMD fellow eyes met the criteria of MPOD < 0.65 and/or PROS length < 35 μm, while only five (17%) control eyes did. After adjusting for age and sex, AMD fellow eyes more frequently satisfied the definition (p < 0.001; 95% confidence interval, 3.50–60.4; odds ratio, 14.6). The combination of MPOD and PROS length may be a useful biomarker for screening predisease AMD patients, although further studies are required in this regard.


Eye ◽  
2012 ◽  
Vol 26 (8) ◽  
pp. 1052-1057 ◽  
Author(s):  
R Raman ◽  
S Biswas ◽  
K Vaitheeswaran ◽  
T Sharma

2012 ◽  
Vol 90 (3) ◽  
pp. e236-e236
Author(s):  
Chrysanthi Tsika ◽  
Miltiadis K. Tsilimbaris ◽  
Maria Makridaki ◽  
Georgios Kontadakis ◽  
Sotiris Plainis ◽  
...  

2016 ◽  
Vol 23 (3) ◽  
Author(s):  
N. O. Dziuba ◽  
A. M. Sergienko

Age-related macular degeneration (AMD) is a leading cause of irreversible loss of central vision in people over 60 years of age. One of the most important risk factors for AMD is decrease in macular pigment optical density (MPOD). Search for new possible ways of (MPOD) improvement in AMD treatment is very important.The objective of the research was to study the indices of macular pigment optical density in patients with the dry form of AMD after two courses of low-energy light therapy and conservative treatment.Material and methods. The main group (MG) included 87 patients (146 eyes) who underwent two courses of low-energy light therapy (LLT) in combination with two courses of conservative treatment in hospital for 10 days at intervals of six months each. The control group (CG) consisted of 75 patients (135 eyes) who underwent only two courses of conservative therapy in the hospital for 10 days at intervals of six months each. Observations were conducted before, after treatment, after 1, 3 and 6 months after each course of treatment. The total period of follow-up was 1 year. LLT was performed using the device Spektra Light (Canada). All patients were generally conducted eye examination. MPOD was measured using densitometer “Maculux praxis” (Germany) by heterochromatic flicker photometry.Results. MPOD index increased from 0.249 ± 0.011 units to 0.360 ± 0.016 units, by 0.111 ± 0.014 units (44.6%) in 1 month after the first course of treatment, up to 0.344 ± 0.015 units, by 0.095 ± 0.013 units (38.2%) after 3 months, up to 0.321 ± 0.014 units, by 0.072 ± 0.013 (28.9%) in 6 months (p<0.05) in patients of MG. Stabilization of the index from 0.248 ± 0.012 units before the treatment and 0.243 ± 0.011 6 months after the first course of treatment (p>0.05) occurred in patients of the KG. MPOD indices increased from 0.321 ± 0.014 units to 0.431 ± 0.017 units, by 0.110 ± 0.016 units (34.3%) in 1 month after the second course of treatment, up to 0.412 ± 0.017 units, by 0.091 ± 0.016 units (28.4%) in 3 months, and up to 0.388 ± 0.016 units, by 0.067 ± 0.015 (20.9%) in 6 months (p<0.05) in patients of the MG. Stabilization of the index from 0.243 ± 0.011 units before the treatment and 0.237 ± 0.011 in 6 months after the second course of treatment (p>0.05) was observed in patients of KG.Conclusions. 1. Statistically significant increase in macular pigment optical density from 0.249 ± 0.011 units to 0.388 ± 0.016, by 0.139 ± 0.014 units (by 55.8%) was noted in patients who underwent two courses of low-energy light therapy in combination with a course of conservative treatment. Macular pigment optical density index did not change in the patients in the control group. 2. Two courses of low-energy light therapy in combination with a course of conservative treatment increases the concentration of macular pigment, as evidenced by the increase in indices of macular pigment optical density in comparison with conservative treatment, during which indices stabilize. 


2021 ◽  
Author(s):  
Xiang Li ◽  
Roberta R. Holt ◽  
Carl L. Keen ◽  
Lawrence S. Morse ◽  
Glenn Yiu ◽  
...  

Abstract Age-related macular degeneration (AMD) is the third leading cause of blindness worldwide. Macular pigment optical density (MPOD), a biomarker for AMD, is a non-invasive measure to assess risk. The macula xanthophyll pigments lutein (L) and zeaxanthin (Z) protect against blue light and provide oxidant defense, which can be indexed by MPOD. This study examined the effects of L- and Z-rich goji berry intake on MPOD and skin carotenoids in healthy individuals. A randomized, unmasked, parallel-arm study was conducted with 27 participants, aged 45–65, who consumed either 28 g of goji berries or a supplement containing 6 mg L and 4 mg Z (LZ), five times weekly for 90 days. After 90 days, MPOD was significantly increased in the goji berry group at 0.25 and 1.75 retinal eccentricities; RE; p = 0.029 and p = 0.044, respectively), while no changes were noted in the LZ group. Skin carotenoids were significantly increased in the goji berry group at day 45 (p = 0.025) and day 90 (p = 0.006), but not in the LZ group. Regular intake of goji berries in a healthy middle-aged population increases MPOD, which may help prevent or delay the development of AMD.


2017 ◽  
Vol 65 (6) ◽  
pp. 477 ◽  
Author(s):  
Mahmut Kaya ◽  
Ayhan Ozyurt ◽  
Nilufer Kocak ◽  
Pınar Akan ◽  
OzlemGursoy Calan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document